AMPK-activated protein kinase activation by Impatiens balsamina L. is related to apoptosis in HSC-2 human oral cancer cells

Pharmacognosy Magazine

Volumn 11, Issue 41, 2015, Pages 136-142

  Shin, Ji Ae ^a   Kwon, Ki Han ^b   Cho, Sung Dae ^a  

^a Chonbuk National University   (South Korea)

^b Kwangju University   (South Korea)

Author keywords

AMP activated protein kinase; apoptosis; Impatiens balsamina L; oral cancer; t Bid

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 9; CYTOCHROME C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMPATIENS BALSAMINA EXTRACT; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; METHANOL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROTEIN; PROTEIN BAD; PROTEIN BAK; T BID PROTEIN; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; DRUG EFFICACY; ENZYME ACTIVATION; HSC 2 CELL LINE; HUMAN; HUMAN CELL; IMPATIENS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUTH CANCER; MTS ASSAY; ORAL CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING;

EID: 84922166027     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.149728     Document Type: Article

References (30)

1. Luo Z, Saha AK, Xiang X, Ruderman NB. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 2005;26:69-76.
2. Fogarty S, Hardie DG. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010;1804:581-91.
3. Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: Control of metabolism and cell growth. Future Oncol 2010;6:457-70.
4. Hadad SM, Baker L, Quinlan PR, Robertson KE, Bray SE, Thomson G, et al. Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer 2009;9:307.
5. Fox MM, Phoenix KN, Kopsiaftis SG, Claffey KP. AMP-Activated Protein Kinase a 2 Isoform suppression in primary breast cancer alters AMPK growth control and apoptotic signaling. Genes Cancer 2013;4:3-14.
6. Garcia-Gil M, Pesi R, Perna S, Allegrini S, Giannecchini M, Camici M, et al. 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003;117:811-20.
7. Appleyard MV, Murray KE, Coates PJ, Wullschleger S, Bray SE, Kernohan NM, et al. Phenformin as prophylaxis and therapy in breast cancer xenografts. Br J Cancer 2012;106:1117-22.
8. Vitale-Cross L, Molinolo AA, Martin D, Younis RH, Maruyama T, Patel V, et al. Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prev Res (Phila) 2012;5:562-73.
9. Sikka A, Kaur M, Agarwal C, Deep G, Agarwal R. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 2012;11:1374-82.
10. Chang HW, Lee YS, Nam HY, Han MW, Kim HJ, Moon SY, et al. Knockdown of ß-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 2013;25:839-47.
11. Zhang T, Hamza A, Cao X, Wang B, Yu S, Zhan CG, et al. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther 2008;7:162-70.
12. Guo T, Lee SS, Ng WH, Zhu Y, Gan CS, Zhu J, et al. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome. Cell Mol Life Sci 2011;68:1983-2002.
13. Shin JA, Jung JY, Ryu MH, Safe S, Cho SD. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization. Mol Pharmacol 2013;83:33-41.
14. Ghate NB, Hazra B, Sarkar R, Mandal N. Heartwood extract of Acacia catechu induces apoptosis in human breast carcinoma by altering bax/bcl-2 ratio. Pharmacogn Mag 2014;10:27-33.
15. Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N, et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene 2005;24:188-98.
16. Rai K, Matsui H, Kaneko T, Nagano Y, Shimokawa O, Udo J, et al. Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells. J Clin Biochem Nutr 2011;49:25-30.
17. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C. Natural products: Promising resources for cancer drug discovery. Anticancer Agents Med Chem 2012;12:49-75.
18. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res 2009;59:365-78.
19. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol 2009;27:2712-25.
20. Su BL, Zeng R, Chen JY, Chen CY, Guo JH, Huang CG. Antioxidant and antimicrobial properties of various solvent extracts from Impatiens balsamina L. stems. J Food Sci 2012;77:C614-9.
21. Lim YH, Kim IH, Seo JJ. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. J Microbiol 2007;45:473-7.
22. Wang YC, Lin YH. Anti-gastric adenocarcinoma activity of 2-Methoxy-1,4-naphthoquinone, an anti-Helicobacter pylori compound from Impatiens balsamina L. Fitoterapia 2012;83:1336-44.
23. Kaur M, Deep G, Jain AK, Raina K, Agarwal C, Wempe MF, et al. Bitter melon juice activates cellular energy sensor AMP-Activated protein kinase causing apoptotic death of human pancreatic carcinoma cells. Carcinogenesis 2013;34:1585-92.
24. Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D. Honokiol activates AMP-Activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res 2012;14:R35.
25. Chen MB, Zhang Y, Wei MX, Shen W, Wu XY, Yao C, et al. Activation of AMP-Activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cell Signal 2013;25:1993-2002.
26. van Delft MF, Huang DC. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 2006;16:203-13.
27. Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med 2010;76:1075-9.
28. Concannon CG, Tuffy LP, Weisová P, Bonner HP, Dávila D, Bonner C, et al. AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J Cell Biol 2010;189:83-94.
29. Kilbride SM, Farrelly AM, Bonner C, Ward MW, Nyhan KC, Concannon CG, et al. AMP-Activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-Apoptotic Bcl-2 homology domain-3-only protein BMF. J Biol Chem 2010;285:36199-206.
30. Yi B, Liu D, He M, Li Q, Liu T, Shao J. Role of the ROS/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells. Oncol Lett 2013;6:583-89.